GFAP and Huntington disease: This late increase is in line with post-mortem studies, that found astrocytosis in moderate, but not the earliest pathological grades of HD in humans [29], and the HD mouse model R6/2, where Glial fibrillary acid protein (GFAP) was elevated in astrocytes of moderate/late disease stages as a sign of classical astrocyte activation [30].